COVID-19

News

scientifically visualization of a coronavirus spike protein

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are "highly unlikely" to be effective against the n

News

Pfizer starts dosing patients with its Omicron COVID shot

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant.

News

FDA clears Gilead's Veklury for COVID outpatients

The FDA has extended the emergency use authorisation for Gilead Sciences' antiviral Veklury to include non-hospitalised patients with COVID-19, extending the uses of the drug.

News

COVID-19 lessons for how pharma should support patient advocacy

Should we be worried about Omicron 'stealth variant' BA.2?

With healthcare systems around the world labouring under the strain of dealing with the Omicron wave of COVID-19 infections, attention is already turning to a new sub-variant that is starti

News